|
|
Today's headline articles Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection.
Today's journal articles
No journal articles today
Do you need further information on any of the agents being evaluated in the trial(s) below? Let us know...
New Clinical Trials
Immune Activation and Drug Absorption in HIV-Infected Patients
Previous Journal Entries
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.
Novel, anionic, anti-viral septapeptides from mosquito cells also protect monkey cells against Dengue virus.
Development of cellular signaling pathway inhibitors as new antivirals against influenza.
Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases.
Synthesis of cephalosporin-3'-diazeniumdiolates: biofilm dispersing NO-donor prodrugs activated by β-lactamase.
Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: Meta-analysis of clinical studies.
Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives.
Staphylococcus aureus supernatant induces the release of mouse β-defensin-14 from osteoblasts via the p38 MAPK and NF-κB pathways.
A small molecule inhibitor of fungal histone acetyltransferase Rtt109.
Optical coherence tomography for assessment of microbicide safety in a small animal model.
Synthesis and antimicrobial activity of novel amphiphilic aromatic amino alcohols.
MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation.
The putative JAK-STAT inhibitor AG490 exacerbates LPS-fever, reduces sickness behavior, and alters the expression of pro- and anti-inflammatory genes in the rat brain.
BLIP-II is a highly potent inhibitor of Klebsiella pneumonia carbapenemase (KPC-2).
In vitro Activity of Doripenem plus Fosfomycin against Drug-Resistant Clinical Blood Isolates.
A Role for Protein Phosphatase 2A in Regulating p38 Mitogen Activated Protein Kinase Activation and Tumor Necrosis Factor-Alpha Expression during Influenza Virus Infection.
Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents.
Small Interfering RNA Targeting Toll-Like Receptor 9 Protects Mice against Polymicrobial Septic Acute Kidney Injury.
Identification and Characterization of a Novel HIV-1 Nucleotide Competing RT Inhibitor Series.
Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines.
|
Today's News Items
No news items selected today
Training Courses & Meetings
No events listed
Previous News Items
U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
|
If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, 
, links through to full analyses relating to pharmaceutical/market developments relating to this work
